Zobrazeno 1 - 10
of 81
pro vyhledávání: '"D. Merante"'
Publikováno v:
Pain Medicine. 20:2074-2077
Autor:
C. Tramontana, J. Soterakis, D. Merante, L. Giglio, J.M. Golbin, C. Shannon, P. O'Shaughnessy
Publikováno v:
B48. CRITICAL CARE: MEASURE FOR MEASURE - QUALITY IMPROVEMENT AND IMPLEMENTATION OF BEST PRACTICE.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yeung-Chul Mun, D. Merante, A. Pfützner, Hubert S. Chou, Kenneth E. Truitt, Y. Choi, J. B. Moberly
Publikováno v:
Diabetes, Obesity and Metabolism. 14:1000-1009
Aims To evaluate the efficacy and safety of rivoglitazone, a peroxisome proliferator-activated receptor γ agonist in the thiazolidinedione class, in subjects with suboptimally controlled type 2 diabetes mellitus (T2DM). Methods Subjects aged ≥18 y
Autor:
Annalisa Blasetti, D. Merante, Emma Altobelli, Fioroni Ma, Sergio Tiberti, R Petrocelli, R. Azzarone, F. Papola, G. Poccia, C. Battistoni, R. Iannarelli, Alberto Verrotti, Stefano Tumini
Publikováno v:
Clinical and Experimental Medicine. 5:72-79
The objective was to evaluate HLA DR/DQ alleles and their risk factor for type 1 diabetes in the Abruzzo region (central Italy). Sixty incident cases from the Abruzzo region were studied together with 120 unrelated control subjects living in the same
Autor:
C. Calderini, Aldo Galluzzo, M. Gobbo, P. Casale, M. Lunetta, Gianluca Iacobellis, R. Carleo, C. Coscelli, D. Valle, A. Camporeale, U. Di Mario, C. Falcelli, F. Paleari, V. Pirrone, D. Merante, Frida Leonetti
Publikováno v:
Acta Diabetologica. 40:187-192
We investigated the use, in a short period, of Humalog Mix25 (Mix25) in a twice-daily administration regimen compared to a twice-daily injection therapy with Humulin 30/70 (30/70) in diabetic patients with Italian dietary habits. We studied 33 type 2
Autor:
F Ambrosi, R. Testa, M. Velussi, Franco Gregorio, S. Manfrini, Flavia Carle, Paolo Filipponi, D. Merante
Publikováno v:
Diabetic Medicine. 16:1016-1024
Summary Aims To assess the effects and safety of increasing sulphonylurea dosages or adding metformin in poorly controlled elderly Type 2 diabetic patients. Methods A 18-month multicentre clinical study was performed on sulphonylurea-treated diabetic
Autor:
Luca Benzi, D. Merante, P Cecchetti, Annamaria Ciccarone, Alessandro Coppini, Paolo Orsini, Graziano Di Cianni, Renzo Navalesi
Publikováno v:
Current Therapeutic Research. 60:314-325
In this double-masked study, we compared the effects of 2 sulfonylureas—gliquidone (Gd) and glibenclamide (Gl)—on metabolic control and on the interaction of insulin with its receptor. After a 3-week run-in period, 43 untreated patients with type
Autor:
Valerio Curto, P. Cecchetti, Filippo Mariano, Annalisa Rosatello, Giuseppina Lanza, Franco Goia, Luigina Capra, D. Merante, Pierluigi L. Cavalli, Luca Benzi
Publikováno v:
Nephrology Dialysis Transplantation. 13:1012-1015
Publikováno v:
The Journal of Pain. 17:S75